Standout Papers

Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Is... 1990 2026 2002 2014 790
  1. Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis (1990)
    Harlan F. Weisman, Michelle K. Leppo et al. Science

Immediate Impact

4 by Nobel laureates 24 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Dendritic cells as shepherds of T cell immunity in cancer
2023 Standout
Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy
2023 Standout
11 intermediate papers

Works of Henry C. Marsh being referenced

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
2019
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
2015
and 5 more

Author Peers

Author Last Decade Papers Cites
Henry C. Marsh 2210 741 397 901 750 93 4.4k
Alan R. Burns 1872 598 514 708 1792 128 5.8k
Rolf Bräuer 1939 799 359 433 1030 104 5.2k
Peter Panizzi 1408 363 398 682 1573 61 4.8k
Raimund W. Kinne 1399 972 518 746 1773 129 6.0k
Jaap D. van Buul 1892 578 175 588 2476 128 5.7k
Akio Ohta 2738 902 104 508 1178 80 5.4k
Kevin Croce 1831 478 357 1038 2372 99 5.9k
Elisabetta Ferrero 1882 705 147 349 1166 112 4.4k
Peter L. E. M. van Lent 1820 815 492 666 2290 129 6.0k
Aline Bözec 1380 855 316 337 1822 108 4.5k

All Works

Loading papers...

Rankless by CCL
2026